TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 220 filers reported holding TG THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.63 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $1,632,991 | -36.0% | 107,363 | -50.2% | 0.00% | -78.6% |
| Q4 2022 | $2,549,684 | +177.1% | 215,527 | +38.8% | 0.01% | +180.0% |
| Q3 2022 | $920,000 | -3.0% | 155,321 | -30.4% | 0.01% | -28.6% |
| Q2 2022 | $948,000 | +4.3% | 223,088 | +851.8% | 0.01% | -30.0% |
| Q2 2021 | $909,000 | +168.1% | 23,438 | +34.6% | 0.01% | +100.0% |
| Q2 2020 | $339,000 | +32.4% | 17,413 | -24.6% | 0.01% | -37.5% |
| Q4 2019 | $256,000 | – | 23,095 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darwin Global Management, Ltd. | 10,451,241 | $157,186,665 | 42.99% |
| M28 Capital Management LP | 339,500 | $5,106,080 | 5.77% |
| Ghost Tree Capital, LLC | 1,100,000 | $16,544,000 | 4.89% |
| Soleus Capital Management, L.P. | 750,300 | $11,284,512 | 1.17% |
| Parkman Healthcare Partners LLC | 275,641 | $4,145,641 | 0.90% |
| 683 Capital Management, LLC | 775,000 | $11,656,000 | 0.87% |
| Leucadia National | 5,100,110 | $76,705,654 | 0.62% |
| Pier Capital, LLC | 233,472 | $3,511,419 | 0.53% |
| Harvest Investment Services, LLC | 40,729 | $612,564 | 0.47% |
| Artal Group S.A. | 511,389 | $7,691 | 0.46% |